EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cell Therapy as Target Therapy against Colon Cancer Stem Cells

Elsa N Garza Treviño, Adriana G Quiroz Reyes iD, Juan Antonio Rojas Murillo iD, David A de la Garza Kalife, Paulina Delgado Gonzalez, Jose F Islas iD, Ana Esther Estrada Rodriguez, Carlos A Gonzalez Villarreal

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24098163 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Elsa N Garza Treviño und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Terapia Celular, Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León, Av. Dr. Jo…. Hauptthemen laut MEDLINE: Colonic Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer stem cells (CSCs) are a small subpopulation of cells within tumors with properties, such as self-renewal, differentiation, and tumorigenicity. CSCs have been proposed as a plausible therapeutic target as they are responsible for tumor recurrence, metastasis, and conventional therapy resistance. Selectively targeting CSCs is a promising strategy to eliminate the propagation of tumor cells and impair overall tumor development. Recent research shows that several immune cells play a crucial role in regulating tumor cell proliferation by regulating different CSC maintenance or proliferation pathways. There have been great advances in cellular immunotherapy using T cells, natural killer (NK) cells, macrophages, or stem cells for the selective targeting of tumor cells or CSCs in colorectal cancer (CRC). This review summarizes the CRC molecular profiles that may benefit from said therapy and the main vehicles used in cell therapy against CSCs. We also discuss the challenges, limitations, and advantages of combining conventional and/or current targeted treatments in the late stages of CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsHumansNeoplastic Stem CellsNeoplasm Recurrence, LocalImmunotherapy

Stichwörter der Autor:innen

T cellscancercancer stem cellscell therapycolon cancer

Autor:innen und Institutionen

  • Laboratorio de Terapia Celular, Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León, Av. Dr. José Eleuterio González 235, Monterrey 64460, Nuevo León, Mexico.
  • Departamento de Ciencias Básicas, Vicerrectoría de Ciencias de la Salud, Universidad de Monterrey, Ignacio Morones Prieto 4500. Jesus M. Garza, San Pedro Garza García 66238, Nuevo León, Mexico.

ORCID-Profile: Adriana G Quiroz Reyes, Juan Antonio Rojas Murillo, Jose F Islas

Zitieren

APA

Garza Treviño, E. N., Quiroz Reyes, A. G., Rojas Murillo, J. A., de la Garza Kalife, D. A., Delgado Gonzalez, P., Islas, J. F., Estrada Rodriguez, A. E., & Gonzalez Villarreal, C. A. (2023). Cell Therapy as Target Therapy against Colon Cancer Stem Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098163

Vancouver

Garza Treviño EN, Quiroz Reyes AG, Rojas Murillo JA, de la Garza Kalife DA, Delgado Gonzalez P, Islas JF, et al. Cell Therapy as Target Therapy against Colon Cancer Stem Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098163

BibTeX
@article{GarzaTrevio2023,
  author = {Garza Treviño, Elsa N and Quiroz Reyes, Adriana G and Rojas Murillo, Juan Antonio and de la Garza Kalife, David A and Delgado Gonzalez, Paulina and Islas, Jose F and Estrada Rodriguez, Ana Esther and Gonzalez Villarreal, Carlos A},
  title = {Cell Therapy as Target Therapy against Colon Cancer Stem Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24098163}
}
Kostenlos starten →